Unknown PHASE2 INTERVENTIONAL 2-arm NCT02934841

Conbercept in Choroidal Neovascularization Secondary to Uveitis

Sponsor: Chongqing Medical University

Conditions Choroidal Neovascularization Uveitis

Updated 5 times since 2017 Last updated: Oct 13, 2016 Started: Nov 30, 2016 Primary completion: Mar 31, 2018 Completion: Nov 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Choroidal Neovascularization and Uveitis, this trial is ongoing. The trial is conducted by Chongqing Medical University and has accumulated 5 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Dec 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jan 2017 — Dec 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chongqing Medical University

Data source: Chongqing Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.